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Abstract 1 
 2 
Objective: Cerebrovascular reactivity can provide a continuously updated 3 individualised target for management of CPP, termed CPPopt. 4 
Data Sources: Here we present a concept method of visualisation of 5 autoregulation based CPPopt using data of  4  severe TBI patients with ICP 6 monitoring.   7 
Conclusions: The visualization method addresses some of the main drawbacks 8 of the original methodology and might bring the potential for its clinical 9 application closer.  10 
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4  
Introduction 1 Current guidelines for management of severe traumatic brain injury (TBI) 2 patients recommend keeping ICP below 20 mmHg and CPP within the range of 3 50-70 mmHg.1 Although some success has been achieved, it ignores substantial 4 injury-specific and patient-specific variability.2 A recent trial showed lack of any 5 important outcome benefits of applying one particular fixed ICP treatment cut-6 off  value.3 One promising approach supports the idea of individualizing 7 perfusion treatment strategies guided by the state of cerebral autoregulation.4-6 8 Cerebrovascular pressure reactivity represents a key element of autoregulation. 9 The pressure reactivity index (PRx) can be determined as the moving correlation 10 coefficient between ABP and ICP.7 With this approach active cerebrovascular 11 reactions can be assessed by observing the response of cerebral blood volume 12 and subsequently ICP to slow spontaneous changes in ABP.8 However, minute-13 by-minute values of PRx vary over time and require averaging to provide 14 meaningful values. Additionally whilst PRx provides a method for assessing 15 autoregulation, it does not, by itself, suggest any particular course of action in 16 patient management.  17 
One useful way of ‘averaging’ PRx and at the same time providing it with an 18 immediate clinical meaning, is to divide its values into different bins according to 19 corresponding predefined CPP ranges. Plotting mean PRx against associated CPP 20 bins frequently produces a U-shaped curve with both hypoperfusion (low CPP) 21 and hyperperfusion (high CPP) associated with worsened cerebrovascular 22 reactivity.4, 5 Employing curve fitting the lowest point of the individual 23 
autoregulation curve can be marked as the ‘optimal’ CPP (CPPopt) value, 24 
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5  corresponding to the CPP where individual autoregulation is the most effective. 1 These calculations can be repeated every minute from a chosen time range of 2 past data samples (moving window) thus producing a time-trend of CPPopt that 3 can be plotted alongside of CPP and ICP (Figure 1a).  Recently, we have 4 demonstrated that larger deviation of CPP from the automatically calculated 5 CPPopt was associated with worse clinical outcome.4 However, the CPPopt trend 6 does not fully reflect the character of the PRx-CPP relationship, nor does it 7 capture its dynamic nature.  In addition, the CPPopt trends can be fairly ‘erratic’ 8 (noisy), and may often contain many gaps where the PRx-CPP curves cannot 9 robustly be fitted. These effects are likely to be detrimental to the process of 10 clinical introduction of the autoregulation guided CPP therapy. 11 
In this study we therefore aim to improve the CPPopt methodology by 12 introducing a new visualization method that may provide insight into the 13 complete characteristics of the CPP-PRx relationship, and its temporal evolution.  14 
Materials and Methods 15 
Patients 16 We present the concepts of the new visualization method using data from four 17 randomly selected severe TBI patients who were admitted to the neurocritical 18 care unit in 2013 and underwent monitoring of ICP as part of the TBI 19 management protocol at the University Medical Center Groningen. The local 20 medical ethics committee waived the need for informed consent. The local TBI 21 protocol aimed at keeping the CPP at approximately 60-70 mmHg and the ICP 22 below 20 mmHg.  23 
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6  
Data acquisition 1 ABP was monitored invasively with an intravascular line connected to a pressure 2 transducer (Baxter Healthcare Corp. CardioVascular Group, Irvine, CA) and 3 zeroed at right atrium level. An intraventricular ICP probe (Raumedic Neurovent, 4 Raumedic AG, Helmbrechts, Germany) was used. All monitoring data were stored 5 using ICM+® software (Cambridge Enterprise, Cambridge, UK, 6 http://www.neurosurg.cam.ac.uk/icmplus). Time-averaged means for ABP, ICP 7 CPP (ABP minus ICP), and PRx 7 were calculated and stored every minute.  8 
Data processing and visualisation 9 
MATLAB (The MathWorks, Inc., Natick, Massachusetts, USA) was used to 10 implement a curve-fitting procedure based on an algorithm described 11 elsewhere4 in order to retrieve the PRx-CPP curves and the corresponding 12 CPPopt values every minute, with a calculation data buffer of 4 hours . 13 Importantly, all the fitted PRx-CPP curves were extended to cover the whole 14 examined range of CPP, from 40 to 120 mmHg. 15 The sequential PRx-CPP curves were then used to create a colour-coded map of 16 PRx-CPP relationship evolution over time (Figure 1b). The time (horizontal) axis 17 represents the position of the moving window for CPPopt calculation. The fitted 18 values of PRx are color-coded for every CPP-time point in the plot. The cool (blue 19 to yellow) colors represent intact cerebral pressure reactivity while impaired 20 pressure reactivity is represented by hot (orange to red) colors. Black areas 21 represent time points for which no CPPopt could be determined. In the second 22 step a non-causal, exponentially weighted moving average (EWMA) filter (n=240 23 data points (i.e. 240 minutes), α=0.005) was applied to the image along the time 24 
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7  axis only. This filter has a low-pass (smoothing) effect in time, and moreover it 1 allows to fill in some of the gaps (of duration not exceeding the filter length) with 2 appropriately weighted average of the preceding and following data values 3 (Figure 1c). In a third step the measured CPP (blue line) values were smoothed 4 with the same EWMA filter and added to the image. Finally, the boundaries of the 5 actual CPP ranges used for individual curve fitting (reflecting the number of 6 included CPP intervals and thereby providing a proxy of the curve reliability) are 7 indicated with black lines. Transparent  overlays on both sides of these black 8 lines make clear within which CPP range the patient was kept and where 9 interpolation of the PRx-CPP curves has taken place. A ‘quality’ indicator bar was 10 added on top of the figure, marking sections of the image where the original gaps 11 were present but which were subsequently interpolated by the EWMA filter 12 (figure 2a).  13 
 14 
Results  15 We illustrate the new CPPopt visualization method for the first three monitoring 16 days of four TBI patients (Figure 2) and provide some retrospective observations 17 that could not have been made with the traditional approach.  18 In patient 1 (Figure 2a), the PRx-CPP landscape indicates that lower CPP values 19 could have probably been well tolerated on day two. By day three however PRx 20 becomes positive over the whole CPP range (complete loss of autoregulation). In 21 such situations, autoregulation cannot be optimised and non CPP orientated, 22 management protocols are probably temporarily more appropriate. In patient 2 23 (Figure 2b) PRx became consistently negative (improving autoregulation) for 24 CPP values around 70 mmHg on day 2 but in the later part of day 3 the patients’ 25 
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8  autoregulation deteriorated considerably suggesting that a more aggressive and 1 targeted management of CPP at higher values (80-90) could  have perhaps been 2 attempted. The PRx-CPP image for patient 3, (Figure 2c), tells the opposite story. 3 The patient started off with global loss of autoregulation, then on day 2 the 4 autoregulation seemed to have recovered but only for a relatively narrow and 5 high (75-90) range of CPPs. Subsequently, from day 3 onwards autoregulation 6 recovered over a broad range (55-75) of CPP. Also patient 4 (Figure 2d) started 7 with global loss of autoregulation with the patient kept at very high CPPs (above 8 90) at end of day 1. Subsequently, from day 3 improved autoregulation in the 9 range 60-75 mmHg might have enabled keeping CPP more ‘stable’ in this range 10 over time.     11 
Discussion and conclusions 12 In our previous work4 we used PRx as a marker of cerebrovascular reactivity to 13 provide a continuously updated individualised target for management of CPP, 14 termed CPPopt. Here, we present a visualisation tool which may help clinicians 15 understand the prevailing physiology in the context of time variation so as to 16 help them in their decision making in individual patients.  17 First, by reducing the complexity of the CPP-PRx relationship to a single value 18 (CPPopt) is an oversimplification that may omit clinically important aspects of 19 autoregulatory behaviour. For example, in addition to a CPPopt target it is also 20 useful to understand what the overall autoregulatory capacity is and how 21 dependent autoregulation is on CPP. Second, the CPPopt time series may 22 sometimes behave quite erratically with large jumps in CPPopt despite relatively 23 stable overall clinical condition of the patient. Finally the current CPPopt 24 
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9  calculation does not always return a valid result at every instant leading to 1 periods with no data (gaps).  2 Such observations naturally reduce the physiological relevance of any single 3 value of CPPopt and are probably in part a consequence of the assumptions of 4 the CPPopt calculation including the assessment of autoregulation itself using the 5 PRx index. Since PRx (and therefore CPPopt) is calculated from spontaneous 6 variations in ICP and ABP rather than diagnostic interventions, it is 7 fundamentally a statistical parameter, with all uncertainties this brings.  8 The proposed visualisation method attempts to address and ameliorate these 9 limitations by providing a continuous representation of the relationship between 10 autoregulation and CPP over time. This allows for not only an indicator of the 11 instantaneous CPPopt but also for the full appreciation of the CPP-dependence of 12 autoregulation past and present. The erratic behaviour and ‘missing values’ of 13 CPPopt is addressed by smoothly interpolating the CPP-PRx behaviour. This 14 smoothing is physiologically plausible when we consider the timescales of the 15 underlying pathobiology likely to be responsible for changes in autoregulation 16 are also likely to be in the order of hours-days rather than minutes.  17 What we describe here is a natural extension of the concept of autoregulatory 18 assessment, providing the full retrospective ‘landscape’ of PRx-CPP relationship 19 extending over the past several hours. Although further methodological 20 improvements and a test of functionality are needed, the proposed visualisation, 21 while addressing some of the problems discussed above, may improve individual 22 CPP management methods based on the status of cerebral autoregulation, 23 current and past. The visualisation tool could be helpful in the development and 24 
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10  fine tuning of an autoregulation-guided CPP treatment protocol that needs 1 prospective testing.   2  3   4 
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13  Figure legends 1 
Figure 1 Visualization of the PRx-CPP relationship and ‘optimal CPP’ (CPPopt) 2 time profile: A) the original visualization showing one curve snapshot and 3 CPPopt time trend (green line)4; B) consecutive PRx-CPP curves plotted using a 4 color map, along the time axis; C) as above, but with exponential smoothing 5 added; the final, proposed, complete visualisation image for CPPopt of this 6 patient is in figure 2a.   7 ABP indicates arterial blood pressure; ICP, intracranial pressure; CPP, cerebral 8 perfusion pressure; CPPopt, optimal cerebral perfusion pressure; PRx, pressure 9 reactivity index; PRxopt, optimal pressure reactivity index.  10  11 
Figure 2 Examples of the new visualisation method applied to 4 selected 12 patients, over the first 3 days of monitoring: A) male, 54 years old, fall from roof, 13 GCS of 7, GOS of 4 (moderate disability) B) male, 16 years old, RTA, GCS of 7, GOS 14 of 5 (low disability) C) female, 19 years old, RTA, GCS of 3, GOS of 1 (Death) and 15 D) male, 58 years old, fall of stairs, GCS of 7, GOS of 1 (Death). The blue line 16 
indicates the patients’ (smoothed) CPP.  The Quality Indicator (QI) above the 17 figure shows ‘grey’ bars indicating interpolated PRx-CPP landscapes (with 18 
exponential smoothing) and ‘black’ bars representing absence of landscape data 19 due to the set smoothing criteria. The ‘transparent’ areas reflect the CPP 20 intervals where the fitted PRx-CPP curves were extended (interpolated on both 21 sides) to cover the whole examined range of CPP from 40 to 120 mmHg. In that 22 respect the ‘black lines’ represent the boundaries of the actual CPP ranges used 23 for individual curve fitting.  24 
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14  GCS indicates Glasgow Coma score (after resuscitation); RTA, Road Traffic 1 Accident; GOS, Glasgow Outcome Scale (at 6 months).   2  3 
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Figure 1 Click here to download Figure Figure 1 600dpi.tif 
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